Hideki Ohno Selected Research

Hideki Ohno Research Topics

Disease

7	Insulin Resistance 01/2017 - 01/2006
7	Obesity 01/2017 - 11/2007
7	Inflammation (Inflammations) 01/2017 - 02/2009
4	Type 2 Diabetes Mellitus (MODY) 09/2016 - 01/2006
4	Hypoxia (Hypoxemia) 01/2014 - 01/2002
3	Cognitive Dysfunction 01/2014 - 12/2011
3	Neoplasms (Cancer) 12/2010 - 10/2004
2	Infections 01/2017 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 04/2014 - 11/2013
2	Dementia (Dementias) 11/2013 - 10/2011
2	Rupture 01/2013 - 01/2012
2	Burns 11/2011 - 03/2003
2	Bacterial Infections (Bacterial Infection) 11/2011 - 11/2009
2	Hypertrophy 05/2008 - 06/2006
2	Neoplasm Metastasis (Metastasis) 01/2007 - 10/2004
1	Body Weight (Weight, Body) 09/2015
1	Hypersensitivity (Allergy) 01/2015
1	Rheumatoid Arthritis 01/2015
1	Chronic Disease (Chronic Diseases) 01/2015
1	Wolfram Syndrome (Syndrome, Wolfram) 11/2013
1	Agnosia (Visual Agnosia) 01/2013
1	Atrophy 01/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2013
1	Chronic Granulomatous Disease 01/2012
1	Multiple Trauma (Multiple Injuries) 11/2011
1	Hemorrhage 12/2010
1	Disease Progression 12/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2010
1	Amyloid Plaque 01/2010
1	Parkinson Disease (Parkinson's Disease) 06/2009
1	Infarction (Infarctions) 01/2008
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Seizures (Absence Seizure) 07/2006
1	Leukocytosis (Pleocytosis) 07/2006
1	Rhabdomyolysis 03/2006
1	Hyperthermia 03/2006
1	Multiple Organ Failure (MODS) 03/2006
1	Hyperglycemia 01/2006
1	Paralysis (Palsy) 01/2006

Drug/Important Bio-Agent (IBA)

7	AdipokinesIBA 01/2017 - 05/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 05/2008
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 02/2009
5	Proteins (Proteins, Gene)FDA Link 01/2015 - 03/2003
4	Messenger RNA (mRNA)IBA 11/2013 - 01/2002
3	Biological ProductsIBA 01/2015 - 03/2003
3	Gliclazide (Diamicron)IBA 11/2007 - 03/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2013
2	GhrelinIBA 01/2015 - 09/2011
2	Peptides (Polypeptides)IBA 01/2015 - 12/2010
2	Indicators and Reagents (Reagents)IBA 01/2014 - 01/2013
2	cobaltous chloride (cobalt(II)chloride)IBA 01/2014 - 11/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 01/2002
2	PalmitatesIBA 08/2013 - 05/2008
2	Transcription Factors (Transcription Factor)IBA 12/2011 - 01/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2006 - 03/2003
2	Insulin (Novolin)FDA Link 06/2006 - 01/2006
2	Superoxide DismutaseIBA 03/2003 - 01/2002
1	MelatoninIBA 09/2015
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 09/2015
1	Growth Hormone (Somatotropin)IBA 01/2015
1	Amyloid beta-PeptidesIBA 04/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014
1	EnzymesIBA 01/2014
1	Neuroprotective AgentsIBA 01/2014
1	Nitric Oxide DonorsIBA 01/2014
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2014
1	Orphan Nuclear ReceptorsIBA 01/2014
1	PolyphenolsIBA 11/2013
1	oligonolIBA 11/2013
1	AndrogensIBA 01/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2012
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2012
1	Interleukin-18 (Interleukin 18)IBA 11/2011
1	Interleukin-18 ReceptorsIBA 11/2011
1	HLA-A*02:01 antigenIBA 12/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2010
1	Angiogenic ProteinsIBA 12/2010
1	HLA-A Antigens (HLA-A)IBA 12/2010
1	Gemcitabine FDA Link 12/2010
1	tau Proteins (tau Protein)IBA 01/2010
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2009
1	Dopamine Agonists (Dopamine Agonist)IBA 06/2009
1	Cabergoline FDA LinkGeneric 06/2009
1	Pramipexole (Mirapex)FDA LinkGeneric 06/2009
1	CytokinesIBA 05/2008
1	AdiponectinIBA 05/2008
1	Therapeutic UsesIBA 11/2007
1	Complementary DNA (cDNA)IBA 01/2007
1	C-Reactive ProteinIBA 07/2006
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2006
1	CalcineurinIBA 06/2006
1	Pharmaceutical PreparationsIBA 06/2006
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2006
1	Dacarbazine (DIC)FDA LinkGeneric 03/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006

Therapy/Procedure

5	Therapeutics 09/2016 - 03/2006
1	Exercise Therapy (Therapy, Exercise) 09/2016
1	Glycemic Control 09/2016
1	Injections 11/2011
1	Conservative Treatment 01/2008